Australian Healthcare Herald
SEE OTHER BRANDS

Catch up with healthcare and wellness news from Australia

Australian Healthcare Herald: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Australian Healthcare Herald.

Press releases published on June 4, 2025

Bigeye Introduces the First Platform for Governing AI Data Usage

Bigeye Introduces the First Platform for Governing AI Data Usage

Bigeye’s AI trust framework defines a new category in enterprise AI trust SAN FRANCISCO, CA, UNITED STATES, June 4, 2025 /⁨EINPresswire.com⁩/ -- Bigeye, the leader in enterprise data observability, today announced the industry’s first AI Trust Platform …

‘Sun’s Out, Deals On’: EIN Presswire’s Summer Special Offers Businesses Big Savings on Press Release Packages

‘Sun’s Out, Deals On’: EIN Presswire’s Summer Special Offers Businesses Big Savings on Press Release Packages

Get press releases for as low as $39.96 each with bonus credits and bulk savings WASHINGTON , DC, UNITED STATES, June 4, 2025 /⁨EINPresswire.com⁩/ -- With summer nearly here, warmer days and vacation plans are already in full swing. But the news cycle …

Quadlytics Raises JPY 600 Million in Series A to Advance the Epileptic Seizure Prediction System

Quadlytics Raises JPY 600 Million in Series A to Advance the Epileptic Seizure Prediction System

KYOTO, JAPAN, June 4, 2025 /⁨EINPresswire.com⁩/ -- Quadlytics Inc., headquartered in Kyoto, is a digital health company developing innovative medical devices. The company has raised JPY 300 million in equity funding through a Series A round led by Lifetime …

Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors

Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors

Phase 11 First-In-Human study designed to assess safety, tolerability, right dose for Phase 2 and early signs of efficacy of 177Lu-RAD202 in individuals with advanced HER2-positive solid tumors Previous clinical proof-of concept data2 for targeting HER-2 …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service